ATP1B1 and Hepatic fibrosis: Endothelial-specific knockout of ATP1B1 resulted in decreased expression of profibrotic factors such as C-X-C motif chemokine ligands 10 and 1 and connective tissue growth factor, while administration of a selective ATP1B1 inhibitor decreased liver fibrosis.